Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial
-
Published:2019-01
Issue:
Volume:106
Page:181-192
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Schneeweiss Andreas,
Möbus Volker,
Tesch Hans,
Hanusch Claus,
Denkert Carsten,
Lübbe Kristina,
Huober Jens,
Klare Peter,
Kümmel Sherko,
Untch Michael,
Kast KarinORCID,
Jackisch Christian,
Thomalla Jörg,
Ingold-Heppner Barbara,
Blohmer Jens-Uwe,
Rezai Mahdi,
Frank Matthias,
Engels Knut,
Rhiem Kerstin,
Fasching Peter Andreas,
Nekljudova Valentina,
von Minckwitz Gunter,
Loibl Sibylle
Funder
Roche
Amgen
Teva
Vifor
Subject
Cancer Research,Oncology
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献